<DOC>
	<DOCNO>NCT00337181</DOCNO>
	<brief_summary>This protocol study clinical course HIV-infection among volunteer receive either placebo injection experimental vaccine combination ALVAC-HIV AIDSVAX B/E prior HIV-1 infection . The study ass whether received experimental vaccine combination slow progression HIV disease compare receive placebo injection .</brief_summary>
	<brief_title>Follow Thai Adult Volunteers With Breakthrough HIV Infection After Participation Preventive HIV Vaccine Trial</brief_title>
	<detailed_description>Prospective cohort study clinical course HIV-1 infection occur candidate HIV-1 vaccination ( breakthrough infection ) ALVAC-HIV ( vcP1521 ) AIDSVAX B/E . This study enroll volunteer become HIV-infected course follow phase III preventive HIV vaccine trial conduct Rayong Chon Buri , Thailand . Volunteers enrol protocol provide additional long-term follow establish whether difference viral load infection ( compare vaccine placebo ) associate altered disease outcome , well provide detailed immunologic virologic assessment volunteer .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>All individual become HIVinfected receive experimental vaccine placebo RV144 clinical tria receive least injection . The volunteer must give write , informed consent . Persons medical psychiatric disorder , judgment investigator ( ) , would interfere serve contraindication adherence study protocol ability give inform consent . Persons become HIVinfected completion RV144 protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>31 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Natural History</keyword>
	<keyword>HIV vaccine</keyword>
	<keyword>Thailand</keyword>
</DOC>